Your payment is in progress...
  +1 (704) 266-3234

Biologics Global Market Report 2020-30: Covid 19 Impact And Recovery Including: 1) By Type: Monoclonal Antibodies (MAbS); Therapeutic Proteins; Vaccines 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others 3) By Route Of Administration: Oral; Parenteral; Others 4) By Drug Classification: Branded Drugs; Generic Drugs 5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs Covering: Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Bristol-Myers Squibb; GlaxoSmithKline Plc.; AbbVie

Published on: May 2020 | From USD $6000 | Published By: THE BUSINESS RESEARCH COMPANY | Number Of Pages: 400

North America was the largest region in the global biologics market, accounting for 53% of the market in 2019. Asia Pacific was the second largest region accounting for 21% of the global biologics market. Africa was the smallest region in the global biologics market.

Biologics are being widely used to provide effective treatment for many complex diseases such as rheumatoid arthritis, psoriasis, CrohnÕs disease that have limited treatment options. There has been a significant advance in the treatment of rheumatoid arthritis patients who do not respond to traditional disease-modifying anti-rheumatic drugs. The key biologics used for the treatment of rheumatoid arthritis include Abatacept (Orencia), Adalimumab (Humira), Anakinra (Kineret), Infliximab (Remicade), and Rituximab (Rituxan). Key biologics used to treat psoriasis include Adalimumab (Humira), Etanercept (Enbrel), Infliximab (Remicade), Secukinumab ( Cosentyx). Cimzia (certolizumab pegol), Humira (adalimumab), and Remicade (infliximab), Tysabri (natalizumab) are biologics that are used to treat CrohnÕs disease.

The biologics market consists of sales of biologics and related services by entities (organizations, sole traders and partnerships) that produce biologics to treat and prevent various microbial diseases and cancers. This industry includes establishments that produce products that are composed of sugars, proteins, nucleic acids, and combination of all these substances isolated from humans, animal and microorganisms or produced from biotechnology methods.

The global biologics market is expected to decline from $269.2 billion in 2019 to $239.2 billion in 2020 at a compound annual growth rate (CAGR) of -11.2%. The decline is mainly due to the worldwide supply and demand failures of drugs due to the COVID-19 outbreak. The biologic drug shortages because of an inadequate production of biologics is hampering the market growth. The inadequate or slowed production is due to the restrictions imposed by governments of various countries to shutdown factories or function with minimal staffing to contain the spread of virus and keep the staff safe. The market is then expected to recover and grow at a CAGR of 15% from 2021 and reach $464.7 billion in 2023.



Biologics Global Market Report 2020-30: Covid 19 Impact and Recovery from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global biologics market as it emerges from the Covid 19 shut down.

Reasons to Purchase
¥ Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
¥ Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
¥ Create regional and country strategies on the basis of local data and analysis.
¥ Identify growth segments for investment.
¥ Outperform competitors using forecast data and the drivers and trends shaping the market.
¥ Understand customers based on the latest market research findings.
¥ Benchmark performance against key competitors.
¥ Utilize the relationships between key data sets for superior strategizing.
¥ Suitable for supporting your internal and external presentations with reliable high quality data and analysis
¥ Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:
Where is the largest and fastest growing market for the biologics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Biologics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the marketÕs historic and forecast market growth by geography. It places the market within the context of the wider biologics market, and compares it with other markets.
¥ The market characteristics section of the report defines and explains the market.
¥ The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
¥ Market segmentations break down market into sub markets.
¥ The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
¥ Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
¥ The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
¥ The biologics market section of the report gives context. It compares the biologics market with other segments of the pharmaceuticals market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, biologics indicators comparison.

Scope

Markets Covered:
1) By Type: Monoclonal Antibodies (MAbS); Therapeutic Proteins; Vaccines
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
3) By Route Of Administration: Oral; Parenteral; Others
4) By Drug Classification: Branded Drugs; Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Subsegments Covered: Anti-Cancer MAbS; Immunological MAbS; Anti-Infective Monoclonal Antibodies (MAbs); Neuropharmacological MABS; Cardiovascular And Cerebrovascular MAbS; Others - Monoclonal Antibodies (MAbs); Metabolic Disorders Therapeutic Proteins; Cancer Therapeutic Proteins; Cardiovascular Therapeutic Proteins; Immunological Therapeutic Proteins; Others - Therapeutic Proteins; Anti-Infective Vaccines; Autoimmunity Vaccines; Others-Vaccines

Companies Mentioned: Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Bristol-Myers Squibb; GlaxoSmithKline Plc.; AbbVie

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, biologics indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

1. Executive Summary
2. Report Structure
3. Biologics Market Characteristics
3.1. Market Definition
3.2. Key Segmentations
4. Biologics Market Product Analysis
4.1. Leading Products/ Services
4.2. Key Features and Differentiators
4.3. Development Products
5. Biologics Market Supply Chain
5.1. Supply Chain
5.2. Distribution
5.3. End Customers
6. Biologics Market Customer Information
6.1. Customer Preferences
6.2. End Use Market Size and Growth
7. Biologics Market Trends And Strategies
8. Biologics Market Size And Growth
8.1. Market Size
8.2. Historic Market Growth, Value ($ Billion)
8.2.1. Drivers Of The Market
8.2.2. Restraints On The Market
8.3. Forecast Market Growth, Value ($ Billion)
8.3.1. Drivers Of The Market
8.3.2. Restraints On The Market
9. Biologics Market Regional Analysis
9.1. Global Biologics Market, 2019, By Region, Value ($ Billion)
9.2. Global Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
9.3. Global Biologics Market, Growth And Market Share Comparison, By Region
10. Biologics Market Segmentation
10.1. Global Biologics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Monoclonal Antibodies (MAbS)
Therapeutic Proteins
Vaccines
10.2. Global Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Hospital Pharmacies
Retail Pharmacies/ Drug Stores
Others
10.3. Global Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Oral
Parenteral
Others
10.4. Global Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Branded Drugs
Generic Drugs
10.5. Global Biologics Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Prescription-Based Drugs
Over-The-Counter Drugs
11. Biologics Market Segments
11.1. Global Monoclonal Antibodies (MAbS) Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion) - Anti-Cancer MAbS; Immunological MAbS; Anti-Infective Monoclonal Antibodies (MAbs); Neuropharmacological MABS; Cardiovascular And Cerebrovascular MAbS; Others - Monoclonal Antibodies (MAbs)
11.2. Global Therapeutic Proteins Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion) - Metabolic Disorders Therapeutic Proteins; Cancer Therapeutic Proteins; Cardiovascular Therapeutic Proteins; Immunological Therapeutic Proteins; Others - Therapeutic Proteins
11.3. Global Vaccines Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion) - Anti-Infective Vaccines; Autoimmunity Vaccines; Others-Vaccines
12. Biologics Market Metrics
12.1. Biologics Market Size, Percentage Of GDP, 2015-2023, Global
12.2. Per Capita Average Biologics Market Expenditure, 2015-2023, Global
13. Asia-Pacific Biologics Market
13.1. Asia-Pacific Biologics Market Overview
13.2. Asia-Pacific, Biologics Market, 2019, By Country, Value ($ Billion)
13.3. Asia-Pacific, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
13.4. Asia-Pacific, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
13.5. Asia-Pacific, Biologics Market Metrics
13.5.1. Per Capita Average Biologics Expenditure, 2015-2023, Asia-Pacific Countries
13.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Asia-Pacific Countries
13.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Asia-Pacific Countries
13.6. Asia-Pacific Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7. Asia-Pacific Biologics Market: Country Analysis
13.7.1. China Biologics Market
13.7.1.1. China Biologics Market Overview
13.7.1.2. China Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.1.3. China Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.2. Australia Biologics Market
13.7.2.1. Australia Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.2.2. Australia Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.3. Hong Kong Biologics Market
13.7.3.1. Hong Kong Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.4. India Biologics Market
13.7.4.1. India Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.4.2. India Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.5. Indonesia Biologics Market
13.7.5.1. Indonesia Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.5.2. Indonesia Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.6. Japan Biologics Market
13.7.6.1. Japan Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.6.2. Japan Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.7. Malaysia Biologics Market
13.7.7.1. Malaysia Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.8. New Zealand Biologics Market
13.7.8.1. New Zealand Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.9. Philippines Biologics Market
13.7.9.1. Philippines Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.10. Singapore Biologics Market
13.7.10.1. Singapore Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.11. South Korea Biologics Market
13.7.11.1. South Korea Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.11.2. South Korea Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.12. Thailand Biologics Market
13.7.12.1. Thailand Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.13. Vietnam Biologics Market
13.7.13.1. Vietnam Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14. Western Europe Biologics Market
14.1. Western Europe Biologics Market Overview
14.2. Western Europe, Biologics Market, 2019, By Country, Value ($ Billion)
14.3. Western Europe, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
14.4. Western Europe, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
14.5. Western Europe, Biologics Market Metrics
14.5.1. Per Capita Average Biologics Expenditure, 2015-2023, Western Europe Countries
14.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Western Europe Countries
14.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Western Europe Countries
14.6. Western Europe Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7. Western Europe Biologics Market: Country Analysis
14.7.1. Austria Biologics Market
14.7.1.1. Austria Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.2. Belgium Biologics Market
14.7.2.1. Belgium Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.3. Denmark Biologics Market
14.7.3.1. Denmark Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.4. Finland Biologics Market
14.7.4.1. Finland Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.5. France Biologics Market
14.7.5.1. France Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.5.2. France Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.6. Germany Biologics Market
14.7.6.1. Germany Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.6.2. Germany Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.7. Ireland Biologics Market
14.7.7.1. Ireland Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.8. Italy Biologics Market
14.7.8.1. Italy Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.9. Netherlands Biologics Market
14.7.9.1. Netherlands Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.10. Norway Biologics Market
14.7.10.1. Norway Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.11. Portugal Biologics Market
14.7.11.1. Portugal Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.12. Spain Biologics Market
14.7.12.1. Spain Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.13. Sweden Biologics Market
14.7.13.1. Sweden Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.14. Switzerland Biologics Market
14.7.14.1. Switzerland Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.15. UK Biologics Market
14.7.15.1. UK Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.15.2. UK Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15. Eastern Europe Biologics Market
15.1. Eastern Europe Biologics Market Overview
15.2. Eastern Europe, Biologics Market, 2019, By Country, Value ($ Billion)
15.3. Eastern Europe, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
15.4. Eastern Europe, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
15.5. Eastern Europe, Biologics Market Metrics
15.5.1. Per Capita Average Biologics Expenditure, 2015-2023, Eastern Europe Countries
15.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Eastern Europe Countries
15.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Eastern Europe Countries
15.6. Eastern Europe Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7. Eastern Europe Biologics Market: Country Analysis
15.7.1. Czech Republic Biologics Market,
15.7.1.1. Czech Republic Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7.2. Poland Biologics Market
15.7.2.1. Poland Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7.3. Romania Biologics Market
15.7.3.1. Romania Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7.4. Russia Biologics Market
15.7.4.1. Russia Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7.4.2. Russia Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16. North America Biologics Market
16.1. North America Biologics Market Overview
16.2. North America, Biologics Market, 2019, By Country, Value ($ Billion)
16.3. North America, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
16.4. North America, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
16.5. North America, Biologics Market Metrics
16.5.1. Per Capita Average Biologics Expenditure, 2015-2023, North America Countries
16.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, North America Countries
16.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, North America Countries
16.6. North America Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7. North America Biologics Market: Country Analysis
16.7.1. Canada Biologics Market
16.7.1.1. Canada Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.2. Mexico Biologics Market
16.7.2.1. Mexico Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.3. USA Biologics Market
16.7.3.1. USA Biologics Market Overview
16.7.3.2. USA Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.3.3. USA Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17. South America Biologics Market
17.1. South America Biologics Market Overview
17.2. South America, Biologics Market, 2019, By Country, Value ($ Billion)
17.3. South America, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
17.4. South America, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
17.5. South America, Biologics Market Metrics
17.5.1. Per Capita Average Biologics Expenditure, 2015-2023, South America Countries
17.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, South America Countries
17.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, South America Countries
17.6. South America Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7. South America Biologics Market: Country Analysis
17.7.1. Argentina Biologics Market
17.7.1.1. Argentina Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7.2. Brazil Biologics Market
17.7.1.1. Brazil Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7.2.2. Brazil Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7.3. Chile Biologics Market
17.7.3.1. Chile Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7.4. Colombia Biologics Market
17.7.4.1. Colombia Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7.5. Peru Biologics Market
17.7.5.1. Peru Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7.6. Venezuela Biologics Market
17.7.6.1. Venezuela Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
18. Middle East Biologics Market
18.1. Middle East Biologics Market Overview
18.2. Middle East, Biologics Market, 2019, By Country, Value ($ Billion)
18.3. Middle East, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
18.4. Middle East, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
18.5. Middle East, Biologics Market Metrics
18.5.1. Per Capita Average Biologics Expenditure, 2015-2023, Middle East Countries
18.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Middle East Countries
18.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Middle East Countries
18.6. Middle East Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
18.7. Middle East Biologics Market: Country Analysis
18.7.1. Saudi Arabia Biologics Market
18.7.1.1. Saudi Arabia Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
18.7.2. Israel Biologics Market
18.7.2.1. Israel Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
18.7.3. Turkey Biologics Market
18.7.3.1. Turkey Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
18.7.4. UAE Biologics Market
18.7.4.1. UAE Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
19. Africa Biologics Market
19.1. Africa Biologics Market Overview
19.2. Africa, Biologics Market, 2019, By Country, Value ($ Billion)
19.3. Africa, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
19.4. Africa, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
19.5. Africa, Biologics Market Metrics
19.5.1. Per Capita Average Biologics Expenditure, 2015-2023, Africa Countries
19.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Africa Countries
19.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Africa Countries
19.6. Africa Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
19.7. Africa Biologics Market: Country Analysis
19.7.1. Egypt Biologics Market
19.7.1.1. Egypt Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
19.7.2. Nigeria Biologics Market
19.7.2.1. Nigeria Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
19.7.3. South Africa Biologics Market
19.7.3.1. South Africa Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
20. Biologics Market Competitive Landscape
20.1. Competitive Market Overview
20.2. Market Shares
20.3. Company Profiles
20.3.1. Johnson & Johnson
20.3.1.1. Company Overview
20.3.1.2. Products And Services
20.3.1.3. Strategy
20.3.1.4. Financial Performance
20.3.2. F. Hoffmann-La Roche Ltd.
20.3.2.1. Company Overview
20.3.2.2. Products And Services
20.3.2.3. Strategy
20.3.2.4. Financial Performance
20.3.3. Bristol-Myers Squibb
20.3.3.1. Company Overview
20.3.3.2. Products And Services
20.3.3.3. Strategy
20.3.3.4. Financial Performance
20.3.4. GlaxoSmithKline Plc.
20.3.4.1. Company Overview
20.3.4.2. Products And Services
20.3.4.3. Strategy
20.3.4.4. Financial Performance
20.3.5. AbbVie
20.3.5.1. Company Overview
20.3.5.2. Products And Services
20.3.5.3. Strategy
20.3.5.4. Financial Performance
21. Key Mergers And Acquisitions In The Biologics Market
22. Market Background: Pharmaceuticals Market
22.1. Pharmaceuticals Market Characteristics
22.2. Pharmaceuticals Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F Growth, By Segment, Value ($ Billion), Global
22.3. Global Pharmaceuticals Market, 2019, By Region, Value ($ Billion)
22.4. Global Pharmaceuticals Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
22.5. Global Pharmaceuticals Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)
23. Recommendations
23.1. Global Biologics Market In 2023- Growth Countries
23.2. Global Biologics Market In 2023- Growth Segments
23.3. Global Biologics Market In 2023- Growth Strategies
24. Appendix
24.1. NAICS Definitions Of Industry Covered In This Report
24.2. Abbreviations
24.3. Currencies
24.4. Research Inquiries
24.5. The Business Research Company
25. Copyright And Disclaimer

Table 1: Historic Market Growth, Value ($ Billion)
Table 2: Forecast Market Growth, Value ($ Billion)
Table 3: Global Biologics Market, 2019, By Region, Value ($ Billion)
Table 4: Global Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
Table 5: Global Biologics Market, Growth And Market Share Comparison, By Region
Table 6: Global Biologics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 7: Global Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 8: Global Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 9: Global Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 10: Global Biologics Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 11: Global Monoclonal Antibodies (MAbS) Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 12: Global Therapeutic Proteins Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 13: Global Vaccines Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 14: Biologics Market Size, Percentage Of GDP, 2015-2023, Global
Table 15: Per Capita Average Biologics Market Expenditure, 2015-2023, Global
Table 16: Asia-Pacific, Biologics Market, 2019, By Country, Value ($ Billion)
Table 17: Asia-Pacific, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
Table 18: Asia-Pacific, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
Table 19: Per Capita Average Biologics Expenditure, 2015-2023, Asia-Pacific Countries
Table 20: Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Asia-Pacific Countries
Table 21: Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Asia-Pacific Countries
Table 22: Asia-Pacific Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 23: China Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 24: China Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 25: Australia Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 26: Australia Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 27: Hong Kong Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 28: India Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 29: India Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 30: Indonesia Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 31: Indonesia Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 32: Japan Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 33: Japan Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 34: Malaysia Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 35: New Zealand Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 36: Philippines Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 37: Singapore Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 38: South Korea Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 39: Thailand Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 40: Vietnam Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 41: Western Europe, Biologics Market, 2019, By Country, Value ($ Billion)
Table 42: Western Europe, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
Table 43: Western Europe, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
Table 44: Per Capita Average Biologics Expenditure, 2015-2023, Western Europe Countries
Table 45: Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Western Europe Countries
Table 46: Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Western Europe Countries
Table 47: Western Europe Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 48: Austria Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 49: Belgium Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 50: Denmark Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 51: Finland Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 52: France Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 53: France Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 54: Germany Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 55: Germany Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 56: Ireland Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 57: Italy Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 58: Netherlands Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 59: Norway Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 60: Portugal Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 61: Spain Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 62: Sweden Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 63: Switzerland Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 64: UK Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 65: UK Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 66: Eastern Europe, Biologics Market, 2019, By Country, Value ($ Billion)
Table 67: Eastern Europe, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
Table 68: Eastern Europe, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
Table 69: Per Capita Average Biologics Expenditure, 2015-2023, Eastern Europe Countries
Table 70: Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Eastern Europe Countries
Table 71: Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Eastern Europe Countries
Table 72: Eastern Europe Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 73: Czech Republic Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 74: Poland Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 75: Romania Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 76: Russia Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 77: Russia Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 78: North America, Biologics Market, 2019, By Country, Value ($ Billion)
Table 79: North America, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
Table 80: North America, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
Table 81: Per Capita Average Biologics Expenditure, 2015-2023, North America Countries
Table 82: Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, North America Countries
Table 83: Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, North America Countries
Table 84: North America Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 85: Canada Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 86: Mexico Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 87: USA Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 88: USA Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 89: South America, Biologics Market, 2019, By Country, Value ($ Billion)
Table 90: South America, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
Table 91: South America, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
Table 92: Per Capita Average Biologics Expenditure, 2015-2023, South America Countries
Table 93: Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, South America Countries
Table 94: Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, South America Countries
Table 95: South America Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 96: Argentina Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 97: Brazil Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 98: Brazil Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 99: Chile Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 100: Colombia Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 101: Peru Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 102: Venezuela Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 103: Middle East, Biologics Market, 2019, By Country, Value ($ Billion)
Table 104: Middle East, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
Table 105: Middle East, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
Table 106: Per Capita Average Biologics Expenditure, 2015-2023, Middle East Countries
Table 107: Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Middle East Countries
Table 108: Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Middle East Countries
Table 109: Middle East Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 110: Saudi Arabia Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 111: Israel Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 112: Turkey Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 113: UAE Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 114: Africa, Biologics Market, 2019, By Country, Value ($ Billion)
Table 115: Africa, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
Table 116: Africa, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
Table 117: Per Capita Average Biologics Expenditure, 2015-2023, Africa Countries
Table 118: Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Africa Countries
Table 119: Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Africa Countries
Table 120: Africa Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 121: Egypt Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 122: Nigeria Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 123: South Africa Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Table 124: Johnson & Johnson Financial Performance
Table 125: F. Hoffmann-La Roche Ltd. Financial Performance
Table 126: Bristol-Myers Squibb Financial Performance
Table 127: GlaxoSmithKline Plc. Financial Performance
Table 128: AbbVie Financial Performance
Table 129: Pharmaceuticals Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Growth, By Segment, Value ($ Billion), Global
Table 130: Global Pharmaceuticals Market, 2019, By Region, Value ($ Billion)
Table 131: Global Pharmaceuticals Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
Table 132: Global Pharmaceuticals Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)
Table 133: Global Biologics Market In 2023- Growth Countries
Table 134: Global Biologics Market In 2023- Growth Segments
Table 135: Global Biologics Market In 2023- Growth Strategies


Figure 1: Historic Market Growth, Value ($ Billion)
Figure 2: Forecast Market Growth, Value ($ Billion)
Figure 3: Global Biologics Market, 2019, By Region, Value ($ Billion)
Figure 4: Global Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
Figure 5: Global Biologics Market, Growth And Market Share Comparison, By Region
Figure 6: Global Biologics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 7: Global Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 8: Global Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 9: Global Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 10: Global Biologics Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Figure 11: Global Monoclonal Antibodies (MAbS) Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 12: Global Therapeutic Proteins Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 13: Global Vaccines Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 14: Biologics Market Size, Percentage Of GDP, 2015-2023, Global
Figure 15: Per Capita Average Biologics Market Expenditure, 2015-2023, Global
Figure 16: Asia-Pacific, Biologics Market, 2019, By Country, Value ($ Billion)
Figure 17: Asia-Pacific, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
Figure 18: Asia-Pacific, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
Figure 19: Per Capita Average Biologics Expenditure, 2015-2023, Asia-Pacific Countries
Figure 20: Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Asia-Pacific Countries
Figure 21: Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Asia-Pacific Countries
Figure 22: Asia-Pacific Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 23: China Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 24: China Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 25: Australia Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 26: Australia Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 27: Hong Kong Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 28: India Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 29: India Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 30: Indonesia Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 31: Indonesia Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 32: Japan Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 33: Japan Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 34: Malaysia Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 35: New Zealand Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 36: Philippines Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 37: Singapore Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 38: South Korea Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 39: Thailand Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 40: Vietnam Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 41: Western Europe, Biologics Market, 2019, By Country, Value ($ Billion)
Figure 42: Western Europe, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
Figure 43: Western Europe, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
Figure 44: Per Capita Average Biologics Expenditure, 2015-2023, Western Europe Countries
Figure 45: Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Western Europe Countries
Figure 46: Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Western Europe Countries
Figure 47: Western Europe Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 48: Austria Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 49: Belgium Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 50: Denmark Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 51: Finland Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 52: France Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 53: France Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 54: Germany Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 55: Germany Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 56: Ireland Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 57: Italy Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 58: Netherlands Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 59: Norway Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 60: Portugal Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 61: Spain Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 62: Sweden Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 63: Switzerland Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 64: UK Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 65: UK Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 66: Eastern Europe, Biologics Market, 2019, By Country, Value ($ Billion)
Figure 67: Eastern Europe, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
Figure 68: Eastern Europe, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
Figure 69: Per Capita Average Biologics Expenditure, 2015-2023, Eastern Europe Countries
Figure 70: Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Eastern Europe Countries
Figure 71: Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Eastern Europe Countries
Figure 72: Eastern Europe Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 73: Czech Republic Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 74: Poland Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 75: Romania Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 76: Russia Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 77: Russia Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 78: North America, Biologics Market, 2019, By Country, Value ($ Billion)
Figure 79: North America, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
Figure 80: North America, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
Figure 81: Per Capita Average Biologics Expenditure, 2015-2023, North America Countries
Figure 82: Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, North America Countries
Figure 83: Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, North America Countries
Figure 84: North America Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 85: Canada Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 86: Mexico Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 87: USA Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 88: USA Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 89: South America, Biologics Market, 2019, By Country, Value ($ Billion)
Figure 90: South America, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
Figure 91: South America, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
Figure 92: Per Capita Average Biologics Expenditure, 2015-2023, South America Countries
Figure 93: Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, South America Countries
Figure 94: Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, South America Countries
Figure 95: South America Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 96: Argentina Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 97: Brazil Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 98: Brazil Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 99: Chile Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 100: Colombia Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 101: Peru Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 102: Venezuela Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 103: Middle East, Biologics Market, 2019, By Country, Value ($ Billion)
Figure 104: Middle East, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
Figure 105: Middle East, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
Figure 106: Per Capita Average Biologics Expenditure, 2015-2023, Middle East Countries
Figure 107: Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Middle East Countries
Figure 108: Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Middle East Countries
Figure 109: Middle East Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 110: Saudi Arabia Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 111: Israel Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 112: Turkey Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 113: UAE Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 114: Africa, Biologics Market, 2019, By Country, Value ($ Billion)
Figure 115: Africa, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
Figure 116: Africa, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
Figure 117: Per Capita Average Biologics Expenditure, 2015-2023, Africa Countries
Figure 118: Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Africa Countries
Figure 119: Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Africa Countries
Figure 120: Africa Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 121: Egypt Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 122: Nigeria Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 123: South Africa Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
Figure 124: Johnson & Johnson Financial Performance
Figure 125: F. Hoffmann-La Roche Ltd. Financial Performance
Figure 126: Bristol-Myers Squibb Financial Performance
Figure 127: GlaxoSmithKline Plc. Financial Performance
Figure 128: AbbVie Financial Performance
Figure 129: Pharmaceuticals Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Growth, By Segment, Value ($ Billion), Global
Figure 130: Global Pharmaceuticals Market, 2019, By Region, Value ($ Billion)
Figure 131: Global Pharmaceuticals Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
Figure 132: Global Pharmaceuticals Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)
Figure 133: Global Biologics Market In 2023- Growth Countries
Figure 134: Global Biologics Market In 2023- Growth Segments
Figure 135: Global Biologics Market In 2023- Growth Strategies

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $6000
USD $9000
USD $12000
Offer

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.